COMPANY

Novoron Bioscience Inc.

HQ: San Diego, CA source · novoron.com ↗ · West Coast

Our approach has demonstrated the ability to provide selective modulation of disease relevant physiology, while sparing homeostatic functions of these receptors. From company website Source · Oct 13, 2026

Keywords: relevant physiology receptors

Location: San Diego, CA · source · Oct 13, 2026

Profile checked Oct 10, 2026

15NIH grants

Funding and NIH signals

NIH award NIH awarded $1.25M (SBIR Phase II 5R44AG097355-02, continuation, notice Jun 3, 2026). NIH RePORTER 5R44AG097355-02 (Jun 3, 2026)
Evidence (1 event)
- Jun 3, 2026 · NIH RePORTER 5R44AG097355-02
  Organization: NOVORON BIOSCIENCE, INC.; City/State: SAN DIEGO, CA; Project number: 5R44AG097355-02; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-06-03; FY total cost (award amount): 1245237; Administering IC: National Institute on Aging; Project title: Human iPSC neural spheroids to screen for compounds that block tau propagation; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Timeline

Jun 3, 2026 Grant Government grant — SBIR: $1.25M (annual award, as published), announced Jun 3, 2026. Agency: NIH/NIA. Source: government award database. source ↗
Sep 16, 2025 Grant Government grant — SBIR: $1.26M (annual award, as published), announced Sep 16, 2025. Agency: NIH/NIA. Source: government award database. source ↗

Funding

Last 2 years.

Jun 3, 2026 Government grant — SBIR: $1.25M (annual award, as published), announced Jun 3, 2026. Agency: NIH/NIA. Source: government award database. source ↗
Sep 16, 2025 Government grant — SBIR: $1.26M (annual award, as published), announced Sep 16, 2025. Agency: NIH/NIA. Source: government award database. source ↗

NIH awards 15

Annual award amounts. Total $3.5M.

Aug 11, 2022 NIH award 3R41AG073080-02S1 FY2022: $110,250 awarded for that fiscal year; activity R41 (STTR); PI STILES, TRAVIS LEE; recipient as written: NOVORON BIOSCIENCE, INC., SAN DIEGO, CA. A novel approach to restricting th source ↗
Aug 10, 2022 NIH award 5R41AG073080-02 FY2022: $348,075 awarded for that fiscal year; activity R41 (STTR); PI STILES, TRAVIS LEE; recipient as written: NOVORON BIOSCIENCE, INC., SAN DIEGO, CA. A novel approach to restricting the source ↗
Apr 29, 2022 NIH award 3R41AG073080-01A1S1 FY2022: $36,750 awarded for that fiscal year; activity R41 (STTR); PI STILES, TRAVIS LEE; recipient as written: NOVORON BIOSCIENCE, INC., SAN DIEGO, CA. A novel approach to restricting t source ↗
Aug 31, 2021 NIH award 1R41AG073080-01A1 FY2021: $349,580 awarded for that fiscal year; activity R41 (STTR); PI STILES, TRAVIS LEE; recipient as written: NOVORON BIOSCIENCE, INC., SAN DIEGO, CA. A novel approach to restricting th source ↗
Jun 10, 2020 NIH award 5R41NS110159-02 FY2020: $354,097 awarded for that fiscal year; activity R41 (STTR); PI STILES, TRAVIS LEE; recipient as written: NOVORON BIOSCIENCE, INC., SAN DIEGO, CA. NOVO-118 as a therapeutic to promote source ↗
Sep 6, 2019 NIH award 1R41NS110159-01A1 FY2019: $353,084 awarded for that fiscal year; activity R41 (STTR); PI STILES, TRAVIS LEE; recipient as written: NOVORON BIOSCIENCE, INC., SAN DIEGO, CA. NOVO-118 as a therapeutic to promo source ↗
Mar 15, 2019 NIH award 5R43NS107093-02 FY2019: $347,542 awarded for that fiscal year; activity R43 (SBIR); PI STILES, TRAVIS LEE; recipient as written: NOVORON BIOSCIENCE, INC., SAN DIEGO, CA. Assessment of NOVO-118 as a regenera source ↗
Mar 19, 2018 NIH award 1R43NS107093-01 FY2018: $347,510 awarded for that fiscal year; activity R43 (SBIR); PI STILES, TRAVIS LEE; recipient as written: NOVORON BIOSCIENCE, INC., SAN DIEGO, CA. Assessment of NOVO-118 as a regenera source ↗
Sep 9, 2016 NIH award 5R43NS092182-02 FY2016: $320,747 awarded for that fiscal year; activity R43 (SBIR); PI STILES, TRAVIS LEE; recipient as written: NOVORON BIOSCIENCE, INC., SAN DIEGO, CA. RAP as a novel therapeutic to promot source ↗
Sep 14, 2015 NIH award 1R43NS092182-01A1 FY2015: $353,106 awarded for that fiscal year; activity R43 (SBIR); PI STILES, TRAVIS LEE; recipient as written: NOVORON BIOSCIENCE, INC., SAN DIEGO, CA. RAP as a novel therapeutic to prom source ↗
Sep 3, 2015 NIH award 3R41EY024803-01S1 FY2015: $39,553 awarded for that fiscal year; activity R41 (STTR); PI BRIGHT, ANDREW TAYLOR; recipient as written: NOVORON BIOSCIENCE, INC., SAN DIEGO, CA. RAP as a therapeutic for regener source ↗
Apr 6, 2015 NIH award 3R41NS086197-01A1S2 FY2015: $80,122 awarded for that fiscal year; activity R41 (STTR); PI STILES, TRAVIS LEE; recipient as written: NOVORON BIOSCIENCE, INC., SAN DIEGO, CA. RAP as a therapeutic compound for source ↗
Sep 9, 2014 NIH award 3R41NS086197-01A1S1 FY2014: $24,982 awarded for that fiscal year; activity R41 (STTR); PI STILES, TRAVIS LEE; recipient as written: NOVORON BIOSCIENCE, INC., SAN DIEGO, CA. RAP as a therapeutic compound for source ↗
Aug 15, 2014 NIH award 1R41EY024803-01 FY2014: $225,000 awarded for that fiscal year; activity R41 (STTR); PI BRIGHT, ANDREW TAYLOR; recipient as written: NOVORON BIOSCIENCE, INC., SAN DIEGO, CA. RAP as a therapeutic for regenera source ↗
Jun 27, 2014 NIH award 1R41NS086197-01A1 FY2014: $224,952 awarded for that fiscal year; activity R41 (STTR); PI STILES, TRAVIS LEE; recipient as written: NOVORON BIOSCIENCE, INC., SAN DIEGO, CA. RAP as a therapeutic compound for source ↗